Showing results (541-550 of 568) with videos related to
Sort By:
Pageof 57
Respiratory Research|October 3, 2014
Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysemaMariana A Antunes, Soraia C Abreu, Fernanda F Cruz, et al.Digestive Diseases and Sciences|January 12, 2026
Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III studyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.Metabolomics : Official Journal of the Metabolomic Society|March 7, 2019
Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South AfricaJeremy P Koelmel, Candice Z Ulmer, Susan Fogelson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 28, 2025
3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Patients with Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized TrialKaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.JAMA|May 4, 2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical TrialSiri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.Journal of Crohn'S & Colitis|June 6, 2023
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III StudyKristina I Aass Holten, Tomm Bernklev, Randi Opheim, et al.Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.Journal of Crohn'S & Colitis|March 13, 2026
Anxiety and depression in newly diagnosed patients with inflammatory bowel disease (the IBSEN III study) compared with the general population in NorwayIngunn Johansen, Milada C Hagen, Stine T Løkkeberg, et al.The Lancet. Rheumatology|April 7, 2024
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trialKaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.Pageof 57